1788 Stock Overview
Supplies medical devices for the renal, cardiac, radiation, dental, oral surgery, and metabolism markets in Taiwan. More details
| Snowflake Score | |
|---|---|
| Valuation | 4/6 |
| Future Growth | 0/6 |
| Past Performance | 3/6 |
| Financial Health | 6/6 |
| Dividends | 5/6 |
My Notes
Capture your thoughts, links and company narrative
Hi-Clearance Inc. Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | NT$139.00 |
| 52 Week High | NT$147.00 |
| 52 Week Low | NT$132.50 |
| Beta | 0.21 |
| 1 Month Change | 0.36% |
| 3 Month Change | 0.72% |
| 1 Year Change | 2.96% |
| 3 Year Change | -1.42% |
| 5 Year Change | 31.13% |
| Change since IPO | 331.68% |
Recent News & Updates
Recent updates
Estimating The Fair Value Of Hi-Clearance Inc. (GTSM:1788)
Apr 17
Hi-Clearance Inc. (GTSM:1788) Is Yielding 4.6% - But Is It A Buy?
Mar 12Hi-Clearance (GTSM:1788) Has Compensated Shareholders With A Respectable 50% Return On Their Investment
Feb 21Does Hi-Clearance (GTSM:1788) Have A Healthy Balance Sheet?
Feb 03
Will Hi-Clearance (GTSM:1788) Multiply In Value Going Forward?
Jan 16Hi-Clearance Inc.'s (GTSM:1788) Stock Has Seen Strong Momentum: Does That Call For Deeper Study Of Its Financial Prospects?
Dec 30Should Hi-Clearance Inc. (GTSM:1788) Be Part Of Your Dividend Portfolio?
Dec 12Shareholders Of Hi-Clearance (GTSM:1788) Must Be Happy With Their 49% Return
Nov 23Shareholder Returns
| 1788 | TW Healthcare | TW Market | |
|---|---|---|---|
| 7D | -0.4% | -1.6% | -2.1% |
| 1Y | 3.0% | -10.6% | 25.6% |
Return vs Industry: 1788 exceeded the TW Healthcare industry which returned -10.6% over the past year.
Return vs Market: 1788 underperformed the TW Market which returned 25.6% over the past year.
Price Volatility
| 1788 volatility | |
|---|---|
| 1788 Average Weekly Movement | 0.7% |
| Healthcare Industry Average Movement | 3.5% |
| Market Average Movement | 4.4% |
| 10% most volatile stocks in TW Market | 7.8% |
| 10% least volatile stocks in TW Market | 2.1% |
Stable Share Price: 1788 has not had significant price volatility in the past 3 months compared to the TW market.
Volatility Over Time: 1788's weekly volatility (1%) has been stable over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 1989 | n/a | Kuo-Shih Chen | www.hiclearance.com.tw |
Hi-Clearance Inc. supplies medical devices for the renal, cardiac, radiation, dental, oral surgery, and metabolism markets in Taiwan. The company offers dialyzers, dialysis and RO machines, and related consumables and drugs; interventional cardiology and radiology, and vascular surgery devices; dental consumables, implant materials, and equipment; and blood glucose monitors, and related consumables and nutrition products, as well as hemodialysis management services. It engages in the design and management of dialysis centers; and sale and service of healthy and natural drinks, as well as operates as an OEM supplier for beverage raw materials and concentrates.
Hi-Clearance Inc. Fundamentals Summary
| 1788 fundamental statistics | |
|---|---|
| Market cap | NT$6.19b |
| Earnings (TTM) | NT$370.20m |
| Revenue (TTM) | NT$4.05b |
16.7x
P/E Ratio1.5x
P/S RatioIs 1788 overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| 1788 income statement (TTM) | |
|---|---|
| Revenue | NT$4.05b |
| Cost of Revenue | NT$2.97b |
| Gross Profit | NT$1.08b |
| Other Expenses | NT$712.35m |
| Earnings | NT$370.20m |
Last Reported Earnings
Sep 30, 2024
Next Earnings Date
n/a
| Earnings per share (EPS) | 8.32 |
| Gross Margin | 26.71% |
| Net Profit Margin | 9.13% |
| Debt/Equity Ratio | 15.5% |
How did 1788 perform over the long term?
See historical performance and comparisonDividends
5.0%
Current Dividend Yield84%
Payout RatioCompany Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2024/12/22 05:30 |
| End of Day Share Price | 2024/12/20 00:00 |
| Earnings | 2024/09/30 |
| Annual Earnings | 2023/12/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .
Analyst Sources
Hi-Clearance Inc. is covered by 1 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
| Analyst | Institution |
|---|---|
| Zhennan Lee | Jih Sun Securities Investment Consulting Co., Ltd. |